Kathleen A. Stringer

5.2k total citations · 1 hit paper
138 papers, 3.7k citations indexed

About

Kathleen A. Stringer is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Kathleen A. Stringer has authored 138 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 29 papers in Pulmonary and Respiratory Medicine and 22 papers in Epidemiology. Recurrent topics in Kathleen A. Stringer's work include Metabolomics and Mass Spectrometry Studies (32 papers), Sepsis Diagnosis and Treatment (16 papers) and Acute Myocardial Infarction Research (14 papers). Kathleen A. Stringer is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (32 papers), Sepsis Diagnosis and Treatment (16 papers) and Acute Myocardial Infarction Research (14 papers). Kathleen A. Stringer collaborates with scholars based in United States, China and Canada. Kathleen A. Stringer's co-authors include Theodore J. Standiford, Alla Karnovsky, Gus R. Rosania, Natalie J. Serkova, Charles Burant, Alan E. Jones, Michael A. Puskarich, Kurt R. Schumacher, Regine L. Caruthers and Robert MacLaren and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kathleen A. Stringer

132 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine

2021 200 citations Gus R. Rosania, Kathleen A. Stringer et al. Metabolites profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen A. Stringer United States	34	1.4k	807	737	489	456	138	3.7k
Jeffrey S. Barrett United States	39	717 0.5×	383 0.5×	642 0.9×	463 0.9×	381 0.8×	192	5.0k
Michael Laposata United States	46	1.7k 1.2×	571 0.7×	914 1.2×	906 1.9×	529 1.2×	195	6.3k
Min Jun Australia	38	2.1k 1.5×	635 0.8×	471 0.6×	1.2k 2.5×	1.3k 2.9×	148	6.5k
Raffaele Landolfi Italy	40	2.1k 1.5×	1.1k 1.4×	536 0.7×	1.2k 2.4×	1.4k 3.0×	205	7.5k
Laurence Corash United States	49	731 0.5×	667 0.8×	616 0.8×	407 0.8×	165 0.4×	192	6.1k
Thomas Marbury United States	41	946 0.7×	1.4k 1.7×	426 0.6×	619 1.3×	1.1k 2.4×	217	5.9k
Roberto Cangemi Italy	37	426 0.3×	844 1.0×	322 0.4×	532 1.1×	1.1k 2.4×	114	3.6k
J. B. L. Hoekstra Netherlands	45	1.3k 0.9×	1.3k 1.6×	550 0.7×	2.0k 4.0×	807 1.8×	151	7.8k
Toshiki Kuno United States	31	905 0.7×	680 0.8×	734 1.0×	1.0k 2.1×	1.7k 3.8×	357	4.7k
Pierre Wallemacq Belgium	47	789 0.6×	1.2k 1.5×	733 1.0×	1.2k 2.4×	443 1.0×	232	7.5k

Countries citing papers authored by Kathleen A. Stringer

Since Specialization

Citations

This map shows the geographic impact of Kathleen A. Stringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen A. Stringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen A. Stringer more than expected).

Fields of papers citing papers by Kathleen A. Stringer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen A. Stringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen A. Stringer. The network helps show where Kathleen A. Stringer may publish in the future.

Co-authorship network of co-authors of Kathleen A. Stringer

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen A. Stringer. A scholar is included among the top collaborators of Kathleen A. Stringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen A. Stringer. Kathleen A. Stringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chanderraj, Rishi, Kathleen A. Stringer, Mohamad Hakam Tiba, et al.. (2026). Pathogen characteristics are key determinants of distinct host response phenotypes of sepsis. Journal of Clinical Investigation. 136(6).

Fry, Christopher, Michael D. Maile, Evan A. Farkash, et al.. (2025). Early Sepsis Metabolic Changes in Kidney and Liver Precede Clinical Evidence of Organ Dysfunction. American Journal of Respiratory Cell and Molecular Biology. 73(2). 299–309. 1 indexed citations

Zirpoli, Gary, William E. Barlow, G. Thomas Budd, et al.. (2023). Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221. Journal of the National Comprehensive Cancer Network. 21(11). 1172–1180.e3. 15 indexed citations

Stringer, Kathleen A., et al.. (2023). Clofazimine-Mediated, Age-Related Changes in Skeletal Muscle Mitochondrial Metabolites. Metabolites. 13(5). 671–671. 1 indexed citations

Stringer, Kathleen A., et al.. (2023). Distinguishing the Concentration- vs. Bioaccumulation-Dependent Immunological and Metabolic Effects of Clofazimine. Pharmaceutics. 15(9). 2350–2350.

Ghini, Veronica, Kathleen A. Stringer, & Claudio Luchinat. (2023). Metabolomics and Its Impact on Health and Diseases. Handbook of experimental pharmacology. 6 indexed citations

Shi, Jiaqi, Lili Zhao, Alexander Raskind, et al.. (2021). Cyst fluid metabolites distinguish malignant from benign pancreatic cysts. Neoplasia. 23(11). 1078–1088. 10 indexed citations

Ward, Kristen M., Kyle J. Burghardt, A. Zarina Kraal, et al.. (2021). Genetic and Metabolite Variability in One-Carbon Metabolism Applied to an Insulin Resistance Model in Patients With Schizophrenia Receiving Atypical Antipsychotics. Frontiers in Psychiatry. 12. 623143–623143. 2 indexed citations

Erb‐Downward, John R., Nicole R. Falkowski, Jennifer D’Souza, et al.. (2020). Critical Relevance of Stochastic Effects on Low-Bacterial-Biomass 16S rRNA Gene Analysis. mBio. 11(3). 31 indexed citations

10.

Tian, Yuzi, Rachel M. Russo, Yongqing Li, et al.. (2020). Serum citrullinated histone H3 concentrations differentiate patients with septic verses non-septic shock and correlate with disease severity. Infection. 49(1). 83–93. 38 indexed citations

11.

Yeomans, Larisa, Jun Hyung Kim, Ping Xiang, et al.. (2019). Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease. SHILAP Revista de lepidopterología. 1 indexed citations

12.

Bowler, Russell P., Chris H. Wendt, Michael B. Fessler, et al.. (2017). New Strategies and Challenges in Lung Proteomics and Metabolomics. An Official American Thoracic Society Workshop Report. Annals of the American Thoracic Society. 14(12). 1721–1743. 37 indexed citations

13.

Puskarich, Michael A., et al.. (2014). Pharmacometabolomics of l -Carnitine Treatment Response Phenotypes in Patients with Septic Shock. Annals of the American Thoracic Society. 12(1). 46–56. 49 indexed citations

14.

Racz, Jennifer, Michael Ford, Lindsay Schmidt, et al.. (2013). Immunophenotyping and Protein Profiling of Fontan-associated Plastic Bronchitis Airway Casts. Annals of the American Thoracic Society. 10(2). 98–107. 18 indexed citations

15.

Serkova, Natalie J., Theodore J. Standiford, & Kathleen A. Stringer. (2011). The Emerging Field of Quantitative Blood Metabolomics for Biomarker Discovery in Critical Illnesses. American Journal of Respiratory and Critical Care Medicine. 184(6). 647–655. 155 indexed citations

16.

Stringer, Kathleen A., et al.. (2008). ACCELERATED DOSING FREQUENCY OF A PULMONARY FORMULATION OF TISSUE PLASMINOGEN ACTIVATOR IS WELL‐TOLERATED IN MICE. Clinical and Experimental Pharmacology and Physiology. 35(12). 1454–1460. 8 indexed citations

17.

Stringer, Kathleen A.. (1998). TIMI Grade Flow, Mortality, and the GUSTO‐III Trial. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(4). 699–705. 15 indexed citations

18.

Stringer, Kathleen A., Swapan K. Bose, & Joe M. McCord. (1997). Antiinflammatory Activity of Tissue Plasminogen Activator in the Carrageenan Rat Footpad Model. Free Radical Biology and Medicine. 22(6). 985–988. 23 indexed citations

19.

Stringer, Kathleen A.. (1996). Biochemical and Pharmacologic Comparison of Thrombolytic Agents. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(5P2). 119S–126S. 14 indexed citations

20.

Stringer, Kathleen A., et al.. (1988). Verapamil Preceded by Calcium in Supraventricular Tachycardia. Drug Intelligence & Clinical Pharmacy. 22(7-8). 575–576. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact